Characteristics of patients receiving budesonide/glycopyrronium/formot

by

Myriam Calle Rubio,1 Juan Antonio Trigueros Carrero,2 Paula Chaparro Briones,3 Luciano Escudero Herrera,3 Michael Pollack,4 Ignacio Hernández Subirá,5 Joaquín Sánchez-Covisa3

1Pneumology Service, H. Clínico San Carlos. Institute for Health Research (IdISSC), Department of Medicine, Complutense University, CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain; 2Buenavista Primary Care Center, Toledo, Spain; 3AstraZeneca Farmacéutica Spain, Madrid, Spain; 4AstraZeneca, LP. BioPharmaceuticals Medical, Wilmington, DE, USA; 5Atrys Health SA, HEOR, Madrid, Spain

Background: Single-inhaler triple therapy with budesonide/glycopyrronium/formoterol fumarate (BGF; Trixeo Aerosphere®) was approved in the European Union in December 2020 for…

Source link

Related posts:

  1. Minecraft 2 Officially Teased by Creator Notch
  2. “Bioprosprecting” scientist sleuthing for crop-aiding fungi brings their spectacular beauty to life – Trinity College Dublin
  3. L’Ascesa di Lamine Yamal: Il Primo a Sfidare Messi e Diventare il Migliore? Analisi Post Barcellona-Inter
  4. Google’s Latest Doodle Lets You Duel the Moon. Here’s How to Play and Win

Leave a Comment